 | • レポートコード：QFJ1-4603 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、腫瘍In-vivo CROの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（製薬・バイオ医薬品産業、医療機器会社、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍In-vivo CROの市場動向 ・企業の競争状況、市場シェア ・腫瘍In-vivo CROの種類別市場規模と予測2016-2027（血液がん、固形腫瘍、その他） ・腫瘍In-vivo CROの用途別市場規模と予測2016-2027（製薬・バイオ医薬品産業、医療機器会社、その他） ・腫瘍In-vivo CROの北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍In-vivo CROの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍In-vivo CROのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍In-vivo CROの中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍In-vivo CROの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Crown Bioscience、Charles River Laboratory、ICON Plc.、Eurofins Scientific、Taconic Biosciences、Covance、EVOTEC、The Jackson Laboratory、Wuxi AppTec.、MI Bioresearch, Inc.、Champion Oncology, Inc.、Xentech） ・結論 |
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible. This report focus on Oncology Based In-vivo CRO.
Market Analysis and Insights: Global Oncology Based In-vivo CRO Market
The global Oncology Based In-vivo CRO market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Based In-vivo CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Based In-vivo CRO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Based In-vivo CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Based In-vivo CRO market.
Global Oncology Based In-vivo CRO Scope and Market Size
Oncology Based In-vivo CRO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Based In-vivo CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Blood Cancer
Solid Tumors
Other
Segment by Application
Pharmaceutical & Biopharmaceutical Industries
Medical Device Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based In-vivo CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oncology Based In-vivo CRO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical & Biopharmaceutical Industries
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based In-vivo CRO Market Perspective (2016-2027)
2.2 Oncology Based In-vivo CRO Growth Trends by Regions
2.2.1 Oncology Based In-vivo CRO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Based In-vivo CRO Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Based In-vivo CRO Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Based In-vivo CRO Industry Dynamic
2.3.1 Oncology Based In-vivo CRO Market Trends
2.3.2 Oncology Based In-vivo CRO Market Drivers
2.3.3 Oncology Based In-vivo CRO Market Challenges
2.3.4 Oncology Based In-vivo CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based In-vivo CRO Players by Revenue
3.1.1 Global Top Oncology Based In-vivo CRO Players by Revenue (2016-2021)
3.1.2 Global Oncology Based In-vivo CRO Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Based In-vivo CRO Revenue
3.4 Global Oncology Based In-vivo CRO Market Concentration Ratio
3.4.1 Global Oncology Based In-vivo CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based In-vivo CRO Revenue in 2020
3.5 Oncology Based In-vivo CRO Key Players Head office and Area Served
3.6 Key Players Oncology Based In-vivo CRO Product Solution and Service
3.7 Date of Enter into Oncology Based In-vivo CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based In-vivo CRO Breakdown Data by Type
4.1 Global Oncology Based In-vivo CRO Historic Market Size by Type (2016-2021)
4.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2022-2027)
5 Oncology Based In-vivo CRO Breakdown Data by Application
5.1 Global Oncology Based In-vivo CRO Historic Market Size by Application (2016-2021)
5.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oncology Based In-vivo CRO Market Size (2016-2027)
6.2 North America Oncology Based In-vivo CRO Market Size by Type
6.2.1 North America Oncology Based In-vivo CRO Market Size by Type (2016-2021)
6.2.2 North America Oncology Based In-vivo CRO Market Size by Type (2022-2027)
6.2.3 North America Oncology Based In-vivo CRO Market Size by Type (2016-2027)
6.3 North America Oncology Based In-vivo CRO Market Size by Application
6.3.1 North America Oncology Based In-vivo CRO Market Size by Application (2016-2021)
6.3.2 North America Oncology Based In-vivo CRO Market Size by Application (2022-2027)
6.3.3 North America Oncology Based In-vivo CRO Market Size by Application (2016-2027)
6.4 North America Oncology Based In-vivo CRO Market Size by Country
6.4.1 North America Oncology Based In-vivo CRO Market Size by Country (2016-2021)
6.4.2 North America Oncology Based In-vivo CRO Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Based In-vivo CRO Market Size (2016-2027)
7.2 Europe Oncology Based In-vivo CRO Market Size by Type
7.2.1 Europe Oncology Based In-vivo CRO Market Size by Type (2016-2021)
7.2.2 Europe Oncology Based In-vivo CRO Market Size by Type (2022-2027)
7.2.3 Europe Oncology Based In-vivo CRO Market Size by Type (2016-2027)
7.3 Europe Oncology Based In-vivo CRO Market Size by Application
7.3.1 Europe Oncology Based In-vivo CRO Market Size by Application (2016-2021)
7.3.2 Europe Oncology Based In-vivo CRO Market Size by Application (2022-2027)
7.3.3 Europe Oncology Based In-vivo CRO Market Size by Application (2016-2027)
7.4 Europe Oncology Based In-vivo CRO Market Size by Country
7.4.1 Europe Oncology Based In-vivo CRO Market Size by Country (2016-2021)
7.4.2 Europe Oncology Based In-vivo CRO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based In-vivo CRO Market Size (2016-2027)
8.2 Asia-Pacific Oncology Based In-vivo CRO Market Size by Type
8.2.1 Asia-Pacific Oncology Based In-vivo CRO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Based In-vivo CRO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Based In-vivo CRO Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Based In-vivo CRO Market Size by Application
8.3.1 Asia-Pacific Oncology Based In-vivo CRO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Based In-vivo CRO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Based In-vivo CRO Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region
8.4.1 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Based In-vivo CRO Market Size (2016-2027)
9.2 Latin America Oncology Based In-vivo CRO Market Size by Type
9.2.1 Latin America Oncology Based In-vivo CRO Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Based In-vivo CRO Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Based In-vivo CRO Market Size by Type (2016-2027)
9.3 Latin America Oncology Based In-vivo CRO Market Size by Application
9.3.1 Latin America Oncology Based In-vivo CRO Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Based In-vivo CRO Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Based In-vivo CRO Market Size by Application (2016-2027)
9.4 Latin America Oncology Based In-vivo CRO Market Size by Country
9.4.1 Latin America Oncology Based In-vivo CRO Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Based In-vivo CRO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based In-vivo CRO Market Size (2016-2027)
10.2 Middle East & Africa Oncology Based In-vivo CRO Market Size by Type
10.2.1 Middle East & Africa Oncology Based In-vivo CRO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Based In-vivo CRO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Based In-vivo CRO Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Based In-vivo CRO Market Size by Application
10.3.1 Middle East & Africa Oncology Based In-vivo CRO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Based In-vivo CRO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Based In-vivo CRO Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country
10.4.1 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Oncology Based In-vivo CRO Introduction
11.1.4 Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Based In-vivo CRO Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc.
11.3.1 ICON Plc. Company Details
11.3.2 ICON Plc. Business Overview
11.3.3 ICON Plc. Oncology Based In-vivo CRO Introduction
11.3.4 ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.3.5 ICON Plc. Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Oncology Based In-vivo CRO Introduction
11.4.4 Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Oncology Based In-vivo CRO Introduction
11.5.4 Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Oncology Based In-vivo CRO Introduction
11.6.4 Covance Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Oncology Based In-vivo CRO Introduction
11.7.4 EVOTEC Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology Based In-vivo CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.8.5 The Jackson Laboratory Recent Development
11.9 Wuxi AppTec.
11.9.1 Wuxi AppTec. Company Details
11.9.2 Wuxi AppTec. Business Overview
11.9.3 Wuxi AppTec. Oncology Based In-vivo CRO Introduction
11.9.4 Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.9.5 Wuxi AppTec. Recent Development
11.10 MI Bioresearch, Inc.
11.10.1 MI Bioresearch, Inc. Company Details
11.10.2 MI Bioresearch, Inc. Business Overview
11.10.3 MI Bioresearch, Inc. Oncology Based In-vivo CRO Introduction
11.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.10.5 MI Bioresearch, Inc. Recent Development
11.11 Champion Oncology, Inc.
11.11.1 Champion Oncology, Inc. Company Details
11.11.2 Champion Oncology, Inc. Business Overview
11.11.3 Champion Oncology, Inc. Oncology Based In-vivo CRO Introduction
11.11.4 Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.11.5 Champion Oncology, Inc. Recent Development
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Oncology Based In-vivo CRO Introduction
11.12.4 Xentech Revenue in Oncology Based In-vivo CRO Business (2016-2021)
11.12.5 Xentech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oncology Based In-vivo CRO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Other
Table 5. Global Oncology Based In-vivo CRO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oncology Based In-vivo CRO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oncology Based In-vivo CRO Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oncology Based In-vivo CRO Market Share by Regions (2016-2021)
Table 9. Global Oncology Based In-vivo CRO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oncology Based In-vivo CRO Market Share by Regions (2022-2027)
Table 11. Oncology Based In-vivo CRO Market Trends
Table 12. Oncology Based In-vivo CRO Market Drivers
Table 13. Oncology Based In-vivo CRO Market Challenges
Table 14. Oncology Based In-vivo CRO Market Restraints
Table 15. Global Oncology Based In-vivo CRO Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oncology Based In-vivo CRO Market Share by Players (2016-2021)
Table 17. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based In-vivo CRO as of 2020)
Table 18. Ranking of Global Top Oncology Based In-vivo CRO Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oncology Based In-vivo CRO Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncology Based In-vivo CRO Product Solution and Service
Table 22. Date of Enter into Oncology Based In-vivo CRO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Based In-vivo CRO Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2016-2021)
Table 26. Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oncology Based In-vivo CRO Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oncology Based In-vivo CRO Revenue Market Share by Application (2016-2021)
Table 30. Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oncology Based In-vivo CRO Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oncology Based In-vivo CRO Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oncology Based In-vivo CRO Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oncology Based In-vivo CRO Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oncology Based In-vivo CRO Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oncology Based In-vivo CRO Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oncology Based In-vivo CRO Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oncology Based In-vivo CRO Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oncology Based In-vivo CRO Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oncology Based In-vivo CRO Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oncology Based In-vivo CRO Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oncology Based In-vivo CRO Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oncology Based In-vivo CRO Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oncology Based In-vivo CRO Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oncology Based In-vivo CRO Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oncology Based In-vivo CRO Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oncology Based In-vivo CRO Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oncology Based In-vivo CRO Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oncology Based In-vivo CRO Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oncology Based In-vivo CRO Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oncology Based In-vivo CRO Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oncology Based In-vivo CRO Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oncology Based In-vivo CRO Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oncology Based In-vivo CRO Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oncology Based In-vivo CRO Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oncology Based In-vivo CRO Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oncology Based In-vivo CRO Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2022-2027) & (US$ Million)
Table 62. Crown Bioscience Company Details
Table 63. Crown Bioscience Business Overview
Table 64. Crown Bioscience Oncology Based In-vivo CRO Product
Table 65. Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 66. Crown Bioscience Recent Development
Table 67. Charles River Laboratory Company Details
Table 68. Charles River Laboratory Business Overview
Table 69. Charles River Laboratory Oncology Based In-vivo CRO Product
Table 70. Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 71. Charles River Laboratory Recent Development
Table 72. ICON Plc. Company Details
Table 73. ICON Plc. Business Overview
Table 74. ICON Plc. Oncology Based In-vivo CRO Product
Table 75. ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 76. ICON Plc. Recent Development
Table 77. Eurofins Scientific Company Details
Table 78. Eurofins Scientific Business Overview
Table 79. Eurofins Scientific Oncology Based In-vivo CRO Product
Table 80. Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 81. Eurofins Scientific Recent Development
Table 82. Taconic Biosciences Company Details
Table 83. Taconic Biosciences Business Overview
Table 84. Taconic Biosciences Oncology Based In-vivo CRO Product
Table 85. Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 86. Taconic Biosciences Recent Development
Table 87. Covance Company Details
Table 88. Covance Business Overview
Table 89. Covance Oncology Based In-vivo CRO Product
Table 90. Covance Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 91. Covance Recent Development
Table 92. EVOTEC Company Details
Table 93. EVOTEC Business Overview
Table 94. EVOTEC Oncology Based In-vivo CRO Product
Table 95. EVOTEC Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 96. EVOTEC Recent Development
Table 97. The Jackson Laboratory Company Details
Table 98. The Jackson Laboratory Business Overview
Table 99. The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 100. The Jackson Laboratory Recent Development
Table 101. Wuxi AppTec. Company Details
Table 102. Wuxi AppTec. Business Overview
Table 103. Wuxi AppTec. Oncology Based In-vivo CRO Product
Table 104. Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 105. Wuxi AppTec. Recent Development
Table 106. MI Bioresearch, Inc. Company Details
Table 107. MI Bioresearch, Inc. Business Overview
Table 108. MI Bioresearch, Inc. Oncology Based In-vivo CRO Product
Table 109. MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 110. MI Bioresearch, Inc. Recent Development
Table 111. Champion Oncology, Inc. Company Details
Table 112. Champion Oncology, Inc. Business Overview
Table 113. Champion Oncology, Inc. Oncology Based In-vivo CRO Product
Table 114. Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 115. Champion Oncology, Inc. Recent Development
Table 116. Xentech Company Details
Table 117. Xentech Business Overview
Table 118. Xentech Oncology Based In-vivo CRO Product
Table 119. Xentech Revenue in Oncology Based In-vivo CRO Business (2016-2021) & (US$ Million)
Table 120. Xentech Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Based In-vivo CRO Market Share by Type: 2020 VS 2027
Figure 2. Blood Cancer Features
Figure 3. Solid Tumors Features
Figure 4. Other Features
Figure 5. Global Oncology Based In-vivo CRO Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical & Biopharmaceutical Industries Case Studies
Figure 7. Medical Device Companies Case Studies
Figure 8. Others Case Studies
Figure 9. Oncology Based In-vivo CRO Report Years Considered
Figure 10. Global Oncology Based In-vivo CRO Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Oncology Based In-vivo CRO Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oncology Based In-vivo CRO Market Share by Regions: 2020 VS 2027
Figure 13. Global Oncology Based In-vivo CRO Market Share by Regions (2022-2027)
Figure 14. Global Oncology Based In-vivo CRO Market Share by Players in 2020
Figure 15. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based In-vivo CRO as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Oncology Based In-vivo CRO Revenue in 2020
Figure 17. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2016-2021)
Figure 18. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2022-2027)
Figure 19. North America Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Oncology Based In-vivo CRO Market Share by Type (2016-2027)
Figure 21. North America Oncology Based In-vivo CRO Market Share by Application (2016-2027)
Figure 22. North America Oncology Based In-vivo CRO Market Share by Country (2016-2027)
Figure 23. United States Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oncology Based In-vivo CRO Market Share by Type (2016-2027)
Figure 27. Europe Oncology Based In-vivo CRO Market Share by Application (2016-2027)
Figure 28. Europe Oncology Based In-vivo CRO Market Share by Country (2016-2027)
Figure 29. Germany Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oncology Based In-vivo CRO Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Oncology Based In-vivo CRO Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Oncology Based In-vivo CRO Market Share by Region (2016-2027)
Figure 39. China Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oncology Based In-vivo CRO Market Share by Type (2016-2027)
Figure 47. Latin America Oncology Based In-vivo CRO Market Share by Application (2016-2027)
Figure 48. Latin America Oncology Based In-vivo CRO Market Share by Country (2016-2027)
Figure 49. Mexico Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oncology Based In-vivo CRO Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Oncology Based In-vivo CRO Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Oncology Based In-vivo CRO Market Share by Country (2016-2027)
Figure 55. Turkey Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Oncology Based In-vivo CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Crown Bioscience Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 59. Charles River Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 60. ICON Plc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 61. Eurofins Scientific Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 62. Taconic Biosciences Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 63. Covance Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 64. EVOTEC Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 65. The Jackson Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 66. Wuxi AppTec. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 67. MI Bioresearch, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 68. Champion Oncology, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 69. Xentech Revenue Growth Rate in Oncology Based In-vivo CRO Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の腫瘍In-vitro CRO市場規模・現状・予測（2021年-2027年） Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharm…- 世界の体外＆体内微小電極アレイ市場規模・現状・予測（2021年-2027年） Microelectrode arrays are also known as multi-electrode arrays. Microelectrode arrays are devices, which have many (tens to thousands) shanks or plates also known as micro-electrodes. Neural signals are delivered by connecting neurons to electronic circuitry. Non-implantable microelectrode arrays ar…
- 世界の前臨床オンコロジーCRO市場規模・現状・予測（2021年-2027年） Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharm…
- 世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年） Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool. Market Analysis and Insights: Global Oncology Blood Testing Market The global Oncology Blood Testing market size is p…
- 前臨床イメージング（In-VIVO）のグローバル市場調査 2019年 The global Preclinical Imaging (In-VIVO) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Preclinical Imaging (In-VIVO) volume and value at global level, regional level and company level. From a glob…